Cellex Cell Professionals, a Germany-based Contract Development and Manufacturing Organisation (CDMO), on Monday reported continued success in its partnership with Gift of Life Biologics, a supplier of cellular starting materials in the US.

Established in 2022, the partnership focuses on supplying tailored cellular starting materials for cell and gene therapy (CGT) manufacturing. It supports research, clinical and commercial production by meeting complex donor specifications.

Gift of Life Biologics provides customised cellular materials from its FDA HCT/P registered and EMA GMP certified facility in the United States. These materials serve as the foundation for Cellex Cell Professionals' CDMO operations in Germany.

Cellex Cell Professionals, with over a decade of CGT experience, leverages this partnership to meet strict regulatory and therapeutic demands. While Cellex operates its own collection centre and donor network, the collaboration with Gift of Life Biologics enables the company to fulfil highly specialised donor requirements for its clients.

The two companies plan to expand their collaboration to support future innovation and global CGT advancements.